Mycophenolate mofetil immunosuppressive therapies increase the incidence of cytomegalovirus infection in renal transplantation
- 1 February 2002
- journal article
- research article
- Published by Elsevier in Transplantation Proceedings
- Vol. 34 (1) , 97
- https://doi.org/10.1016/s0041-1345(01)02683-5
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantationNephrology Dialysis Transplantation, 2000
- Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patientsClinical Transplantation, 2000
- Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation?1Clinical Transplantation, 1998
- Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejectionThe Lancet, 1995